"As President Trump weighs marijuana rescheduling in the coming weeks, the DEA's track record reveals years of mismanagement, empty promises, and patients left waiting," stated MMJ CEO Duane Boise.

FLT3 Inhibitors for Acute Myeloid Leukemia Market to Reach USD 440 Million by 2025, Projected to Grow at 8% CAGR Through 2032 The global FLT3 inhibitors for acute myeloid leukemia market is poised to ...

Black Book Research Flash Survey of 126 Healthcare Investors Pinpoints Largely Untapped, High-Conviction Markets for Startups ...

Black Book Research Marks Its 12th Year on the Ground in Verona with Independent, Vendor-Agnostic Insights for Navigating Epic's Provider-First Culture MADISON, WI / ACCESS Newswire / August 16, 2025 ...

The Culture Media Market is undergoing a dynamic transformation, responding to the surging needs of biopharmaceutical ...

Science and technology rely on each other. Scientific progress fuels new technologies, while better technology helps science ...

The artificial intelligence in drug discovery market represents a transformative frontier in pharmaceutical research, ...

Have you ever pondered over the ingredients list on your toothpaste tube and wondered what those scientific names mean, let ...

Now Offering Veterinary Hemodialysis, Therapeutic Plasma Exchange, and Hemoperfusion BEND, OR / ACCESS Newswire / August 12, ...

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System AtrophyBOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ...

LAVAL, QC / ACCESS Newswire / August 15, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and ...

The global refurbished ultrasound devices market is set to witness a CAGR of ~8% in the next 5 years. Cost effectiveness & ...